Dementia currently affects approximately 900,000 people in the UK and is projected to affect 1.6 million by 2040 as the population ages. Alzheimer's disease, the most common form, involves the accumulation of amyloid-beta plaques and tau tangles in the brain over decades before the cognitive symptoms that produce a diagnosis become apparent. By the time a person is referred to a memory clinic and receives a dementia diagnosis, the underlying neuropathological process has typically been active for 15 to 20 years. This extended pre-clinical phase represents an enormous and currently underutilised opportunity for prevention: the 2020 Lancet Commission on Dementia Prevention identified twelve modifiable risk factors, including physical inactivity, hypertension, obesity, type 2 diabetes, smoking, excess alcohol, depression, low educational engagement, social isolation, hearing loss, air pollution, and traumatic brain injury, that together account for approximately 40 percent of dementia cases worldwide. For adults on the Isle of Man, this means four in ten dementia cases are potentially preventable through lifestyle modification.
The Twelve Modifiable Risk Factors for Dementia
The Lancet Commission on Dementia Prevention, Intervention and Care, published in 2020, updated its modifiable risk factor analysis to include 12 factors across the life course, each with epidemiological evidence for independent contribution to dementia risk. Physical inactivity is one of the largest individual contributors, with the population attributable fraction for inactivity estimated at 2 percent of dementia cases globally. Hypertension, particularly mid-life hypertension between ages 45 and 65, is associated with a doubling of dementia risk, reflecting its effects on small vessel disease and cerebrovascular blood flow. Obesity in mid-life, type 2 diabetes, and smoking each contribute independently, and the clustering of these factors in the same individual compounds risk multiplicatively.
The practical implication of the Lancet Commission findings is that the same lifestyle factors addressed in the cardiovascular and metabolic health components of the Longevity MOT, physical activity, blood pressure, metabolic health, smoking status, and alcohol consumption, are also the primary modifiable drivers of dementia risk. An adult on the Isle of Man who optimises their cardiovascular fitness, maintains a healthy body weight, prevents or reverses insulin resistance, keeps blood pressure within optimal range, and avoids smoking and excess alcohol is simultaneously doing the most evidence-based intervention available for dementia prevention. There is no separate brain health programme: the lifestyle that protects the heart and the metabolism protects the brain.
Cognitive Assessment in the Longevity MOT
The cognitive component of the Longevity MOT at Zhen Wellness does not diagnose dementia; that requires specialist neurological evaluation. What it provides is a baseline assessment of current cognitive function in key domains including memory, attention, processing speed, and executive function, using validated brief neuropsychological tools that are sensitive to the early changes that precede clinical cognitive impairment. Tools such as the Montreal Cognitive Assessment, the Cognitive Assessment Battery, and domain-specific tests provide data that can be compared against age-matched reference values to identify anyone whose performance is below the expected range for their demographic and that can be compared at future assessments to detect any meaningful change over time.
For most adults in their 40s and 50s attending the Longevity MOT, the cognitive assessment will be entirely normal and will serve primarily as a baseline for future comparison. For a smaller proportion, the assessment may reveal subtle performance that is below expected for age in specific domains, warranting closer monitoring, further evaluation, or more aggressive intervention on the identified lifestyle risk factors. Even for those with entirely normal results, the information about modifiable dementia risk factors and the most evidence-based preventive strategies is valuable, because the most effective time to implement these strategies is before any sign of cognitive change, not after.
Vascular Cognitive Risk: Blood Pressure, Diabetes, and the Brain
Vascular contributions to cognitive impairment and dementia, the brain damage caused by large and small vessel disease in the cerebral vasculature, account for approximately 20 to 30 percent of dementia cases directly and contribute to the progression of Alzheimer's pathology in a much higher proportion. The risk factors for vascular cognitive impairment are identical to those for cardiovascular disease: hypertension, type 2 diabetes, dyslipidaemia, smoking, and physical inactivity. White matter hyperintensities, areas of small vessel disease visible on brain MRI, accumulate silently over years in people with uncontrolled hypertension and are associated with subsequent cognitive decline, gait abnormalities, and depression before clinical dementia becomes apparent.
The blood pressure and metabolic health assessments in the Longevity MOT are therefore simultaneously addressing the most important modifiable risk factors for both cardiovascular disease and vascular cognitive impairment. An adult whose Longevity MOT identifies elevated blood pressure and early insulin resistance is receiving information that simultaneously justifies intervention for their heart health and their brain health. The additive motivational impact of understanding that the same intervention addresses multiple serious conditions is significant and is one of the reasons the integrated approach of the Longevity MOT produces better engagement with lifestyle change than condition-specific assessments.
Sleep, Stress, and the Brain: Overlooked Components
Sleep is a direct contributor to cognitive health through its role in the glymphatic system, the brain's waste clearance mechanism that operates primarily during slow-wave sleep to clear amyloid-beta and tau proteins from the interstitial space. Chronic sleep deprivation, defined as consistently fewer than seven hours per night, is associated with higher rates of amyloid accumulation in observational studies and with impaired cognitive performance on multiple domains in experimental sleep restriction studies. The Longevity MOT sleep assessment includes sleep duration, sleep quality assessed through validated questionnaires, and screening for common sleep disorders including obstructive sleep apnoea, which independently doubles dementia risk through its effects on cerebral oxygenation and sleep architecture.
Chronic psychological stress and its biological correlate, chronically elevated cortisol, directly damage the hippocampus, the brain structure most critical for memory formation and most vulnerable to Alzheimer's pathology. The hippocampus has high density of glucocorticoid receptors, making it particularly sensitive to cortisol-induced neurotoxicity over sustained exposure. Adults on the Isle of Man who identify as chronically stressed, with poor sleep and limited recovery, are exposing their hippocampus to a sustained hormonal stress that accelerates the neuronal loss preceding dementia. Addressing stress and sleep through the evidence-based interventions recommended in the Longevity MOT programme directly addresses this mechanism.
- The Lancet Commission identifies 12 modifiable factors accounting for 40% of dementia cases; all are addressable through lifestyle
- Cardiovascular health protection and dementia prevention share the same lifestyle interventions: there is no separate brain programme
- Cognitive assessment at baseline allows meaningful comparison at future assessments to detect early changes
- Vascular dementia shares risk factors with cardiovascular disease: blood pressure and metabolic health directly protect the brain
- Sleep below 7 hours per night impairs glymphatic clearance of amyloid-beta; sleep apnoea doubles dementia risk
- Chronic cortisol elevation damages the hippocampus; stress and sleep management directly reduce neurodegeneration risk
- The best time to assess cognitive baseline and implement prevention is in the 40s and 50s, not after symptoms appear
Sources
- Livingston, G., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 396(10248), 413-446.
- Kokkinos, P., et al. (2022). Cardiorespiratory fitness and mortality risk across the spectra of age, race, and sex. JAMA Network Open, 5(5), e2218174.
- Xie, L., et al. (2013). Sleep drives metabolite clearance from the adult brain. Science, 342(6156), 373-377.
- Sapolsky, R.M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Archives of General Psychiatry, 57(10), 925-935.
- Nasreddine, Z.S., et al. (2005). The Montreal Cognitive Assessment: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695-699.